Stanford researchers hope new technique will flip lymphoma protein’s normal action — from preventing cell death to triggering it. October 22, 2024 - By Rachel Tompa A new molecule developed by Stanford Medicine researchers (turquoise and yellow) tethers two proteins (purple and red) that together switch on self-destruction genes in cancer cells. Ella Maru Studio Our bodies divest themselves of 60 billion cells every day through a natural process of cell culling and turnover called apoptosis. The...